Acute and prolonged toxicity assessment of Cannabis sativa extract in rodents and lagomorphs

Cannabinoids offer a novel pharmacotherapeutic approach and can complement other medications to address unmet clinical needs in numerous patients, which has led to a global increase in the use of these products. No significant safety concerns have been identified in preclinical studies involving CBD...

Full description

Saved in:
Bibliographic Details
Main Authors: Alana C. Costa, Arquimedes Gasparotto, Jr., Alana A.K. Garcia, Cícero A.C. Pereira, Emerson L.B. Lourenço, Helena P.G. Joaquim
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Toxicology Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214750025000368
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832583851250024448
author Alana C. Costa
Arquimedes Gasparotto, Jr.
Alana A.K. Garcia
Cícero A.C. Pereira
Emerson L.B. Lourenço
Helena P.G. Joaquim
author_facet Alana C. Costa
Arquimedes Gasparotto, Jr.
Alana A.K. Garcia
Cícero A.C. Pereira
Emerson L.B. Lourenço
Helena P.G. Joaquim
author_sort Alana C. Costa
collection DOAJ
description Cannabinoids offer a novel pharmacotherapeutic approach and can complement other medications to address unmet clinical needs in numerous patients, which has led to a global increase in the use of these products. No significant safety concerns have been identified in preclinical studies involving CBD and THC. However, the available data on the toxicity of combined CBD and THC are still inconclusive. Evaluating full-spectrum Cannabis sativa extracts is even more complex since whole extracts and isolated phytomolecules do not act in the same way. Given the growing interest in cannabinoid-containing products for human use and the fact that most cannabis treatments utilize entire inflorescence rather than isolated compounds, the current studies aim to evaluate the preclinical safety of a full-spectrum composition (THC, CBD, minor cannabinoids, terpenes, and flavonoids) Cannabis sativa extract (CSE). This research includes acute (single dose, with animals monitored for 14 days to assess potential effects) and long-term treatments (6 months for rodents and 9 months for rabbits) to assess safety and tolerance. This study demonstrates that a full-spectrum Cannabis sativa extract has a favorable safety profile in both acute and prolonged toxicity studies in rodents and rabbits. In acute toxicity tests, the extract did not show any significant behavioral or physiological changes after oral or intraperitoneal administration. Additionally, administering the extract acutely to rabbits had minimal impact on the central nervous, cardiovascular, and respiratory systems, with only a temporary reduction in motor activity at the highest dose. Prolonged administration of 6 months in rats and 9 months in rabbits did not lead to significant changes in organ histopathology, body weight, or behavior. Although liver enzymes were elevated at the highest doses, other biochemical and hematological parameters remained unchanged. CSE was well-tolerated, as no serious adverse effects were observed; however, a reduction in motor activity was noted in the highest dose group, highlighting the need for further investigation, which is proposed for future studies.
format Article
id doaj-art-881c969b56e5472caa64490b4d941f4d
institution Kabale University
issn 2214-7500
language English
publishDate 2025-06-01
publisher Elsevier
record_format Article
series Toxicology Reports
spelling doaj-art-881c969b56e5472caa64490b4d941f4d2025-01-28T04:14:38ZengElsevierToxicology Reports2214-75002025-06-0114101918Acute and prolonged toxicity assessment of Cannabis sativa extract in rodents and lagomorphsAlana C. Costa0Arquimedes Gasparotto, Jr.1Alana A.K. Garcia2Cícero A.C. Pereira3Emerson L.B. Lourenço4Helena P.G. Joaquim5GreenCare Pharma, Vinhedo, SP, BrazilLaboratory of Electrophysiology and Cardiovascular Pharmacology, Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, MS, BrazilLaboratory of Pharmacology and Toxicology of Natural Products, Universidade Paranaense, Umuarama, PR, BrazilGreenCare Pharma, Vinhedo, SP, BrazilLaboratory of Pharmacology and Toxicology of Natural Products, Universidade Paranaense, Umuarama, PR, BrazilGreenCare Pharma, Vinhedo, SP, Brazil; Correspondence to: GreenCare Pharma, Division of Medical & Scientific Affairs, 255 Edgar Marchiori st, Vinhedo ZIP 13288-006, Brazil.Cannabinoids offer a novel pharmacotherapeutic approach and can complement other medications to address unmet clinical needs in numerous patients, which has led to a global increase in the use of these products. No significant safety concerns have been identified in preclinical studies involving CBD and THC. However, the available data on the toxicity of combined CBD and THC are still inconclusive. Evaluating full-spectrum Cannabis sativa extracts is even more complex since whole extracts and isolated phytomolecules do not act in the same way. Given the growing interest in cannabinoid-containing products for human use and the fact that most cannabis treatments utilize entire inflorescence rather than isolated compounds, the current studies aim to evaluate the preclinical safety of a full-spectrum composition (THC, CBD, minor cannabinoids, terpenes, and flavonoids) Cannabis sativa extract (CSE). This research includes acute (single dose, with animals monitored for 14 days to assess potential effects) and long-term treatments (6 months for rodents and 9 months for rabbits) to assess safety and tolerance. This study demonstrates that a full-spectrum Cannabis sativa extract has a favorable safety profile in both acute and prolonged toxicity studies in rodents and rabbits. In acute toxicity tests, the extract did not show any significant behavioral or physiological changes after oral or intraperitoneal administration. Additionally, administering the extract acutely to rabbits had minimal impact on the central nervous, cardiovascular, and respiratory systems, with only a temporary reduction in motor activity at the highest dose. Prolonged administration of 6 months in rats and 9 months in rabbits did not lead to significant changes in organ histopathology, body weight, or behavior. Although liver enzymes were elevated at the highest doses, other biochemical and hematological parameters remained unchanged. CSE was well-tolerated, as no serious adverse effects were observed; however, a reduction in motor activity was noted in the highest dose group, highlighting the need for further investigation, which is proposed for future studies.http://www.sciencedirect.com/science/article/pii/S2214750025000368CannabisCannabinoidsToxicitySafety
spellingShingle Alana C. Costa
Arquimedes Gasparotto, Jr.
Alana A.K. Garcia
Cícero A.C. Pereira
Emerson L.B. Lourenço
Helena P.G. Joaquim
Acute and prolonged toxicity assessment of Cannabis sativa extract in rodents and lagomorphs
Toxicology Reports
Cannabis
Cannabinoids
Toxicity
Safety
title Acute and prolonged toxicity assessment of Cannabis sativa extract in rodents and lagomorphs
title_full Acute and prolonged toxicity assessment of Cannabis sativa extract in rodents and lagomorphs
title_fullStr Acute and prolonged toxicity assessment of Cannabis sativa extract in rodents and lagomorphs
title_full_unstemmed Acute and prolonged toxicity assessment of Cannabis sativa extract in rodents and lagomorphs
title_short Acute and prolonged toxicity assessment of Cannabis sativa extract in rodents and lagomorphs
title_sort acute and prolonged toxicity assessment of cannabis sativa extract in rodents and lagomorphs
topic Cannabis
Cannabinoids
Toxicity
Safety
url http://www.sciencedirect.com/science/article/pii/S2214750025000368
work_keys_str_mv AT alanaccosta acuteandprolongedtoxicityassessmentofcannabissativaextractinrodentsandlagomorphs
AT arquimedesgasparottojr acuteandprolongedtoxicityassessmentofcannabissativaextractinrodentsandlagomorphs
AT alanaakgarcia acuteandprolongedtoxicityassessmentofcannabissativaextractinrodentsandlagomorphs
AT ciceroacpereira acuteandprolongedtoxicityassessmentofcannabissativaextractinrodentsandlagomorphs
AT emersonlblourenco acuteandprolongedtoxicityassessmentofcannabissativaextractinrodentsandlagomorphs
AT helenapgjoaquim acuteandprolongedtoxicityassessmentofcannabissativaextractinrodentsandlagomorphs